In this role, Cheryl will lead Wellcome’s broad programme of discovery research, as well as research related to our three health challenge areas: mental health, infectious diseases, and the health effects of global heating.
I am honoured to have the opportunity to be a part of Wellcome’s mission to improve human health.
Wellcome has clear ambitions to push the boundaries of discovery science for health and to move the needle on some of the world’s most pressing health challenges.
I very much look forward to working with my new colleagues in and around Wellcome and our many research partners in the UK and across the globe.
Prior to taking up her role at the New York Genome Center, Cheryl held leadership posts at the Howard Hughes Medical Institute, one of the USA’s biggest philanthropic medical research funders.
Cheryl is also a member of the governing boards of the Sainsbury Wellcome Centre for Neural Circuits and Behaviour(opens in a new tab) and of Genome Research Ltd, the parent company of the Wellcome Sanger Institute(opens in a new tab) and Wellcome Genome Campus(opens in a new tab).
Jeremy Farrar, Director of Wellcome, said: "I’m delighted that Cheryl will be joining us. Among a highly competitive field she stood out as a leader with a great breadth and depth of experience in medical research. She brings a combination of strategic ambition alongside deft operational management, and a record of leading successful innovation.
"She will oversee and develop our new health challenge areas and our crucial discovery research programme, as well as be a key advocate for the positive and inclusive culture we want to nurture throughout the world of research through our role as a funder."
She is expected to take up the post in May 2021.